Revance Therapeutics is Drug Delivery in United States that focus on Revance Therapeutics Inc business. Founded in 2002. They cover business area such as Revance Therapeutics Inc, aesthetic and therapeutic offering, its neuromodulator product, DaxibotulinumtoxinA, Injection, prestige aesthetic portfolio, dermal filler, its main product, Product, maximum revenue, research, development, aesthetic and therapeutic product.
2002
( 22 years old in 2024 )
Revance Therapeutics Inc
-
1222 Demonbreun Street
Nashville, TN 37203
United States
Private
Revance Therapeutics Incaesthetic and therapeutic offeringits neuromodulator productDaxibotulinumtoxinAInjectionprestige aesthetic portfoliodermal fillerits main productProductmaximum revenueresearchdevelopmentaesthetic and therapeutic product
* We use standard office opening hours in near Revance Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Revance Therapeutics is Drug Delivery business from United States that founded in 2002 (22 years old in 2024), Revance Therapeutics business is focusing on Revance Therapeutics Inc.
Revance Therapeutics headquarter office and corporate office address is located in 1222 Demonbreun Street Nashville, TN 37203 United States.
Revance Therapeutics was founded in United States.
In 2024, Revance Therapeutics is currently focus on Revance Therapeutics Inc sector.
Above is snippet of Google Trends for "Revance Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Revance Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
